← Back to Search

PAD Education Video for Peripheral Arterial Disease

N/A
Recruiting
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient undergoing surgery for PAD in Division of Vascular Surgery at Northwestern Memorial Hospital
Must not have
Inability to complete study protocol
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to six-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether an online multimedia patient education video, in addition to the current education regimen, will improve peripheral artery disease (PAD) knowledge, activation, and self-care engagement among patients undergoing surgery for PAD.

Who is the study for?
The STEPUP trial is for patients scheduled for surgery to treat Peripheral Arterial Disease (PAD) at Northwestern Memorial Hospital. It's not open to those who were in the pilot study, have already seen the PAD education video, or can't consent or follow the study rules.
What is being tested?
This trial tests if adding an online patient education video about PAD to existing educational materials helps improve patients' understanding of their condition and self-care after surgery. Participants are split into two groups: one with standard education and one with additional video content.
What are the potential side effects?
Since this intervention involves an educational video, there aren't any direct medical side effects expected from participating in this clinical trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having surgery for PAD at Northwestern Memorial Hospital.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot follow the study's required steps.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to six-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to six-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Readiness to change self-care engagement
Secondary study objectives
Activation level
PAD knowledge and beliefs
Self-efficacy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Current education regimenActive Control1 Intervention
Participants will be given a PAD pamphlet and ad hoc verbal teaching by vascular providers.
Group II: InterventionActive Control1 Intervention
Participants will be given the current education regimen and watch a 20 minute online PAD education video.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,652 Previous Clinical Trials
961,365 Total Patients Enrolled
28 Trials studying Peripheral Arterial Disease
4,924 Patients Enrolled for Peripheral Arterial Disease

Media Library

Peripheral Arterial Disease Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05445375 — N/A
~21 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top